Beauty Farm Medical and Health Industry Inc. reported the repurchase of 12,500 ordinary shares on 23 April 2026 through on-exchange transactions, paying between HK$20.86 and HK$21.10 per share. The aggregate consideration amounted to approximately HK$0.26 million.

Following the transaction, outstanding shares (excluding treasury shares) declined by 0.005 % to 249.99 million, while treasury share holdings rose to 1.61 million. The company’s total issued share count remains at 251.59 million.

The buyback forms part of the mandate approved on 27 June 2025, which authorises the repurchase of up to 23.58 million shares. To date, 1.61 million shares have been repurchased under this mandate, representing 0.68 % of the share base on the approval date.

Under Hong Kong listing rules, Beauty Farm is restricted from issuing new shares or disposing of treasury shares until 23 May 2026. The board confirmed that the repurchase complied with all applicable regulatory requirements.